Abstract:1321 Purpose: To investigate the correlation of radiomic features of the primary tumor on F-18 Fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and computed tomography (CT) images with epidermal growth factor receptor (EGFR) mutation status in patients with advanced lung adenocarcinoma (ADC). Methods: In this retrospective study, seventy-one patients with stage IV lung adenocarcinoma (AJCC eighth edition) were included, who underwent pretreatment 18F-FDG-PET/CT scanning and EGFR mutation tests. Age, gender, smoking status and pathological information was collected from the institutional information system. The median age was 58 (range, 27-84) and 32 (45.1%) were female. Fifty-eight CT and seventy PET quantitative features were extracted from volumes of each primary tumor using CGITA software (Chang-Gung Memorial Hospital, Taiwan). The x2 test was used for categorical variables between 2 groups. The correlation between radiomic features was investigated to address collinearity issues. The highly correlated features (correlation > 0.8) were regarded as dependent features, which were not considered in this analysis. Thus, 38 of 128 features were considered as mutually independent features for analysis of factors associated with EGFR mutation. The method of logistic regression used was forward-conditional. The stepwise probability was set to 0.05 for entry and 0.10 for removal. The classification cut-off was 0.5 and the maximum number of iterations was 20. Omnibus tests of model coefficients were also conducted. Receiver operating characteristic (ROC) curves for each model were constructed and the AUC was calculated with EGFR mutation status. P<0.05 was considered as significantly statistical difference. SPSS 20.0 software and R 3.5.0 software were used for the statistical analysis. Results: Thirty-nine patients were EGFR mutation (exon 19:26; exon 20: 1; exon 21: 12), whereas 32 patients were wild-type. The EGFR Mutation was significantly associated with gender of patients (P=0.026). 21 PET and 17 CT features were considered as mutually independent features for analysis of factors associated with EGFR mutation. Four PET (cooccurance second angular moment, cooccurance contrast, intensity size zone low intensity large zone emphasis and texture spectrum max spectrum) and two CT quantitative features (intensity size zone high intensity zone emphasis and normalized cooccurance second angular moment) were independent predictors of EGFR mutation in advanced lung adenocarcinoma in multiple logistic regression analysis. Receiver operating characteristic (ROC) curves showed that the predictive ability of the model with clinical variables and radiomic features was more precise than the model with radiomic features alone (AUC, 0.893 vs 0.785). Conclusions: Radiomic features of primary tumors had potential to predict EGFR mutation in advanced lung adenocarcinoma. Radiomic features or combined with clinical variables can provide useful information regarding EGFR mutations when adequate specimen for EGFR mutation test could not be obtained in patients with advanced lung adenocarcinoma.

Correlations Study Between 18 F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma.

18F-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography-Based Radiomic Features for Prediction of Epidermal Growth Factor Receptor Mutation Status and Prognosis in Patients with Lung Adenocarcinoma

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.

Primary metabolic tumor volume from <SUP>18</SUP>F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients

Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.

Lung Adenocarcinoma: Development of Nomograms Based on PET/CT Images for Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes

Correlation Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Pathological Subtypes of Invasive Lung Adenocarcinoma and Prognosis.

Correlation of Radiomic Features with Epidermal Growth Factor Receptor Mutation Stat Us in Advanced Lung Adenocarcinoma..

A Predictive Model of EGFR Mutation Status in Patients with Lung Adenocarcinoma Based on PET/CT Metabolic Indexes and Clinicopathological Variables

Predictive Value of Intratumor Metabolic and Heterogeneity Parameters on [18F]FDG PET/CT for EGFR Mutations in Patients with Lung Adenocarcinoma

Optimal <SUP>18</SUP>F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study

High-resolution Computed Tomography Findings Independently Predict Epidermal Growth Factor Receptor Mutation Status in Ground-Glass Nodular Lung Adenocarcinoma.

[Semiquantitative Parameters of 18F-FDG PET/CT, Gene Mutation States of Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase in Prognosis Evaluation of Patients with Lung Adenocarcinoma].

Value of Combining PET/CT and Clinicopathological Features in Predicting EGFR Mutation in Lung Adenocarcinoma with Bone Metastasis.

18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer.

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

SUV-derived Parameters Assessed on F-18-FDG PET/CT Predict EGFRMutation in Lung Adenocarcinoma Patients: the Construction of CART Predictive Model

Quantitative F-18-FDG PET Analysis in Survival Rate Prediction of Patients with Non-Small Cell Lung Cancer

Value of 18F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations

Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study

Predicting EGFR Mutation Subtypes in Lung Adenocarcinoma Using 18F-FDG PET/CT Radiomic Features